Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.
Elucidata has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in September 2022.
Elucidata's investors include IvyCap Ventures, F-Prime, Eight Roads Ventures, Hyperplane, TiE SoCal Angels.
Elucidata is headquartered in Cambridge, United States.
Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.
Elucidata is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elucidata — Funding & Investors." VCBacked, September 27, 2022, https://www.vcbacked.co/company/elucidata. Accessed August 14, 2026.
VCBacked. (2022). Elucidata — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/elucidata
{{cite web |title=Elucidata — Funding & Investors |url=https://www.vcbacked.co/company/elucidata |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated